CoChat

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences

Abstract

AIMS: The aim of this study was to determine the extent to which adherence to individual vascular medications, assessed by different methods, influences the absolute and relative risks (RRs) of cardiovascular disease (CVD) and all-cause mortality. METHODS AND RESULTS: We performed a systematic review and meta-analysis of prospective epidemiological studies (cohort, nested case-control, or clinical trial) identified through electronic searches using MEDLINE, Web of Science, EMBASE, and Cochrane databases, involving adult populations (≥ 18 years old) and reporting risk estimates of cardiovascular medication adherence with any CVD (defined as any fatal or non-fatal coronary heart disease, stroke or sudden cardiac death) and/or all-cause mortality (defined as mortality from any cause) outcomes. Relative risks were combined using random-effects models. Forty-four unique prospective studies comprising 1 978 919 non-overlapping participants, with 135 627 CVD events and 94 126 cases of all-cause mortality. Overall, 60% (95% CI: 52-68%) of included participants had good adherence (adherence ≥ 80%) to cardiovascular medications. The RRs (95% CI) of development of CVD in those with good vs. poor (<80%) adherence were 0.85 (0.81-0.89) and 0.81 (0.76-0.86) for statins and antihypertensive medications, respectively. Corresponding RRs of all-cause mortality were 0.55 (0.46-0.67) and 0.71 (0.64-0.78) for good adherence to statins and antihypertensive agents. These associations remained consistent across subgroups representing different study characteristics. Estimated absolute risk differences for any CVD associated with poor medication adherence were 13 cases for any vascular medication, 9 cases for statins and 13 cases for antihypertensive agents, per 100 000 individuals per year. CONCLUSION: A substantial proportion of people do not adhere adequately to cardiovascular medications, and the prevalence of suboptimal adherence is similar across all individual CVD medications. Absolute and relative risk assessments demonstrate that a considerable proportion of all CVD events (~9% in Europe) could be attributed to poor adherence to vascular medications alone, and that the level of optimal adherence confers a significant inverse association with subsequent adverse outcomes. Measures to enhance adherence to help maximize the potentials of effective cardiac therapies in the clinical setting are urgently required.

Overview

Integrity signals

Registry

Crossref · 10.1093/eurheartj/eht295

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Research works printed but not linked: 2

  1. 10.1345/aph.1a333 · doi:10.1345/aph.1a333 · Paper page
  2. Rothman K Greenland S . Modern Epidemiology. 2nd ed. Lippincott Williams & Wilkins: Philadelphia; 1998.

Cited by

See all 1,000

Metadata

Authors
Chowdhury, R., Khan, H., Heydon, E., Shroufi, A., Fahimi, S., Moore, C., Stricker, B., Mendis, S., Hofman, A., Mant, J., & Franco, O. H.
Affiliations
  • University of Cambridge (GB)
  • Erasmus MC (NL)
  • World Health Organization (CH)
Venue
European Heart Journal
Published
2013-08-01
Volume
34
Issue
38
Pages
2940-2948
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2113320440
Cited by
931
References
38
Citations by year
2026: 43 · 2025: 70 · 2024: 95 · 2023: 71 · 2022: 90 · 2021: 81 · 2020: 76 · 2019: 79 · 2018: 83 · 2017: 86 · 2016: 70 · 2015: 49 · 2014: 33 · 2013: 2
FWCI
7.56
Type
journal article
Language
en
Open access
closed
Locations
  • European Heart Journal (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • National Institute for Health and Care Research (NF-SI-0512-10165)
  • British Heart Foundation (RG/08/014/24067)
  • Medical Research Council (MR/L003120/1)
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
medication adherence, cardiovascular drugs, cardiovascular disease, all-cause mortality, statins, antihypertensive drugs, coronary artery disease, stroke, sudden cardiac death, cardiovascular risk, risk difference, relative risk, cardiovascular risk reduction, adherence measurement methods, primary prevention, secondary prevention
MeSH terms
Adult, Aged, Cardiovascular Agents, Cardiovascular Diseases, Cause of Death, Epidemiologic Methods, Humans, Middle Aged, Drug Monitoring, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. https://app.cochat.ai/papers/10.1093/eurheartj/eht295
The paper
Chowdhury, R., Khan, H., Heydon, E., Shroufi, A., Fahimi, S., Moore, C., Stricker, B., Mendis, S., Hofman, A., Mant, J., & Franco, O. H. (2013). Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. European Heart Journal. https://doi.org/10.1093/eurheartj/eht295

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.